Erin K. Nyren‐Erickson
Wells Fargo (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Proteoglycans and glycosaminoglycans research, Peptidase Inhibition and Analysis, Advanced biosensing and bioanalysis techniques, Computational Drug Discovery Methods
Most-Cited Works
- → A disintegrin and metalloproteinase-12 (ADAM12): Function, roles in disease progression, and clinical implications(2013)69 cited
- → Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9(2010)23 cited
- → Fluorescent Liposomes for Differential Interactions with Glycosaminoglycans(2011)17 cited
- → Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation(2014)11 cited
- → Glycosaminoglycan-Mediated Selective Changes in the Aggregation States, Zeta Potentials, and Intrinsic Stability of Liposomes(2012)9 cited
- → Lipid Nanoparticle‐Mediated Detection of Proteins(2011)1 cited